Threonine Tyrosine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy

From the Departments of Thoracic/Head and Neck Medical Oncology, Melanoma Medical Oncology, Genomic Medicine, Translational Molecular Pathology, and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030; The Campbell Family Institute for Breast Cancer Research at Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 2M9; Frederick National Laboratory for Cancer Research, Frederick, MD 21702-1201.

[1]  E. Dmitrovsky,et al.  Engaging Anaphase Catastrophe Mechanisms to Eradicate Aneuploid Cancers , 2018, Molecular Cancer Therapeutics.

[2]  E. Dmitrovsky,et al.  Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers , 2018, Proceedings of the National Academy of Sciences.

[3]  S. Pastorino,et al.  Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma , 2017, Oncogene.

[4]  E. Dmitrovsky,et al.  Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer , 2017, Journal of the National Cancer Institute.

[5]  T. Mak,et al.  Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer , 2017, Proceedings of the National Academy of Sciences.

[6]  Narendra Kumar Patel,et al.  Discovery of Pyrazolo[1,5-a]pyrimidine TTK Inhibitors: CFI-402257 is a Potent, Selective, Bioavailable Anticancer Agent. , 2016, ACS medicinal chemistry letters.

[7]  E. A. G. de Oliveira,et al.  Mps1 (Monopolar Spindle 1) Protein Inhibition Affects Cellular Growth and Pro-Embryogenic Masses Morphology in Embryogenic Cultures of Araucaria angustifolia (Araucariaceae) , 2016, PloS one.

[8]  R. V. van Montfort,et al.  Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach. , 2016, Journal of medicinal chemistry.

[9]  T. Mak,et al.  Targeting Mitosis in Cancer: Emerging Strategies. , 2015, Molecular cell.

[10]  G. Rancati,et al.  Aneuploidy and chromosomal instability in cancer: a jackpot to chaos , 2015, Cell Division.

[11]  Narendra Kumar Patel,et al.  The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents. , 2015, Journal of medicinal chemistry.

[12]  Sue Biggins,et al.  Signalling dynamics in the spindle checkpoint response , 2014, Nature Reviews Molecular Cell Biology.

[13]  J. Murnane,et al.  DNA-damage response during mitosis induces whole-chromosome missegregation. , 2014, Cancer discovery.

[14]  Dan-dan Wang,et al.  Expression and Function Analysis of Mitotic Checkpoint Genes Identifies TTK as a Potential Therapeutic Target for Human Hepatocellular Carcinoma , 2014, PloS one.

[15]  E. Rozenblum,et al.  Multi-Layered Cancer Chromosomal Instability Phenotype , 2013, Front. Oncol..

[16]  Tammara A. Wood,et al.  Identification of cell cycle–regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors , 2013, Molecular biology of the cell.

[17]  M. Korc,et al.  Selective Inhibition of Pancreatic Ductal Adenocarcinoma Cell Growth by the Mitotic MPS1 Kinase Inhibitor NMS-P715 , 2013, Molecular Cancer Therapeutics.

[18]  L. Galluzzi,et al.  Characterization of novel MPS1 inhibitors with preclinical anticancer activity , 2013, Cell Death and Differentiation.

[19]  Stephen S. Taylor,et al.  The Spindle Assembly Checkpoint , 2012, Current Biology.

[20]  Günter P. Wagner,et al.  Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples , 2012, Theory in Biosciences.

[21]  A. Chinnaiyan,et al.  Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer. , 2012, Neoplasia.

[22]  S. Pavey,et al.  Defective Cell Cycle Checkpoints as Targets for Anti-Cancer Therapies , 2011, Front. Pharmacol..

[23]  J. Chan.  A Clinical Overview of Centrosome Amplification in Human Cancers , 2011, International journal of biological sciences.

[24]  Aaron Rogers,et al.  Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1 , 2011, Molecular Cancer Therapeutics.

[25]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[26]  Antonella Isacchi,et al.  Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase. , 2010, Cancer research.

[27]  O. Kallioniemi,et al.  Analysis of Kinase Gene Expression Patterns across 5681 Human Tissue Samples Reveals Functional Genomic Taxonomy of the Kinome , 2010, PloS one.

[28]  E. Dmitrovsky,et al.  Cyclin E Transgenic Mice: Discovery Tools for Lung Cancer Biology, Therapy, and Prevention , 2010, Cancer Prevention Research.

[29]  Andrea Musacchio,et al.  Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1–C-Mad2 core complex , 2010, The Journal of cell biology.

[30]  E. Dmitrovsky,et al.  MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. , 2010, The Journal of clinical investigation.

[31]  Taebo Sim,et al.  Small Molecule Kinase Inhibitors Provide Insight into Mps1 Cell Cycle Function , 2010, Nature chemical biology.

[32]  T. Chou.  Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.

[33]  Alexander Pertsemlidis,et al.  Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. , 2009, Genes & development.

[34]  Alexey Khodjakov,et al.  Centrosome Amplification Can Initiate Tumorigenesis in Flies , 2008, Cell.

[35]  M. Winey,et al.  Preventing the degradation of mps1 at centrosomes is sufficient to cause centrosome reduplication in human cells. , 2007, Molecular biology of the cell.

[36]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[37]  E. Dmitrovsky,et al.  Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas , 2007, Proceedings of the National Academy of Sciences.

[38]  J. Minna,et al.  High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. , 2006, Cancer research.

[39]  A. Nobel,et al.  The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.

[40]  K. Kelsey,et al.  Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer , 2005, British Journal of Cancer.

[41]  E. Nigg,et al.  Kinetochore localization and microtubule interaction of the human spindle checkpoint kinase Mps1 , 2004, Chromosoma.

[42]  M. Winey,et al.  Human Mps1 protein kinase is required for centrosome duplication and normal mitotic progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  K. Vermeulen,et al.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.

[44]  Lionel Arnaud,et al.  Human Mps1 kinase is required for the spindle assembly checkpoint but not for centrosome duplication , 2002, The EMBO journal.

[45]  J. Labbé,et al.  Mps1 Is a Kinetochore-Associated Kinase Essential for the Vertebrate Mitotic Checkpoint , 2001, Cell.

[46]  Eric L. Weiss,et al.  Yeast spindle pole body duplication gene MPS1 encodes an essential dual specificity protein kinase. , 1995, The EMBO journal.